Author

B. Brunton

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Baum· 1 shared A. Bexon· 1 shared A. Roesler· 1 shared C. A. Kyratsous· 1 shared C. Gnanadurai· 1 shared C. Jerde· 1 shared C. Ziegler· 1 shared E. K. Phillips· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Baum

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Development and validation of IMMUNO-COV: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2

R. Vandergaast, T. Carey, S. Reiter, P. Lech, C. Gnanadurai, M. Tesfay, J. Buehler, L. Suksanpaisan, S. Naik, B. Brunton, J. Recker, M. Haselton, C. Ziegler, A. Roesler, J. R. Mills, , S. J. Russell

The paper develops and validates IMMUNO-COV, a high-throughput assay that accurately quantifies SARS-CoV-2-neutralizing antibodies in human sera.

bioRxiv · May 26, 2020 · PreprintImmunology

TIM-1 SERVES AS A NONREDUNDANT RECEPTOR FOR EBOLA VIRUS, ENHANCING VIREMIA AND PATHOGENESIS

B. Brunton, K. Rogers, E. K. Phillips, R. B. Brouillette, R. Bouls, N. S. Butler, W. Maury

This study shows TIM-1 enhances Ebola virus pathogenesis by increasing virus load and mortality in mice, suggesting TIM-1 as a nonredundant receptor for EBOV.

bioRxiv · Nov 8, 2018Microbiology